Zika Virus

Outbreak of Zika Virus Disease

Latest update of this page: 15.11.2016

Latest developments

07 November 2016 - Flash report - Audio conference of the Health Security Committee (HSC) (27 October 2016)

28 October 2016 - Rapid risk assessment: Zika virus disease epidemic. Ninth update, 28 October 2016

05 September2016 - Flash report - Audio conference of the Health Security Committee (HSC) (21 September 2016)

All recent developments

What is the Zika Virus?

Since May 2015, Zika virus disease – an emerging viral disease transmitted by Aedes mosquito bites - has been spreading in the Americas and the Caribbean, following the first cases reported in Brazil. The arrival of the virus has been associated with a steep increase in the birth of babies with abnormally small heads and in cases of Guillain-Barré syndrome. Based on a growing body of research, there is now a scientific consensus that Zika virus is the cause of microcephaly and Guillain-Barré syndrome (GBS). The magnitude of the risk that Zika virus infection during pregnancy will result in malformations in the foetus is under investigation, but remains unknown at present. As the spread of Zika virus disease continues in the American Region, the risk of Zika-infected travellers entering Europe increases. Imported cases of Zika virus infection have been reported in several European countries. However, at this stage, in the EU the virus has only been found in travellers returning from countries affected by the virus.

On 1 February 2016, the World Health Organisation (WHO) declared the Zika Virus outbreak to be a Public Health Emergency of International Concern.

How is the Zika virus being managed in Europe?

During a health crisis, such as the Zika virus outbreak, whilst individual Member States are responsible for their own health measures, the Commission works closely with the WHO (which is responsible for the protection of health at international level), and in line with Decision 1082/2013/EU on serious cross-border threats to health, supports EU governments in ensuring a coherent and well-coordinated response to cross-border health threats. The Decision lays down the responsibilities for risk assessment for the threats covered by its scope. As regards communicable diseases the European Centre for Disease Prevention and Control (ECDC) is in charge of providing risk assessment.

Watch the video for more information on Crisis Management for health threats in the EU

The video is available in English, French, German, Italian, Spanish, Polish






At the request of the Commission the European Centre for Disease Prevention and Control (ECDC) carried out a risk assessment on Zika virus disease (latest update published on 28 October). According to the ECDC, the "risk of transmission of the Zika virus infection is extremely low in the EU" during the early spring as the climate conditions are not suitable to the mosquito which carries the virus. On the basis of the ECDC risk assessment, options for measures to control the infection and minimise the risk for travellers to affected countries are shared with health authorities in Member States.

Also in accordance with the Serious Cross-Border Health Threats Decision, the EU's Early Warning and Response System for medical emergencies has been activated, and the Health Security Committee (HSC), bringing together EU Member States and the Commission, meets regularly to coordinate Zika virus prevention and readiness (next meeting will take place in the near future).

Information to travellers and EU residents in affected areas

As part of their response, Member States may choose to use the information to travellers and EU residents in affected areas  Member States presented in ECDC’s Raid Risk Assessments (RRAs).

You can find the latest RRAs here, on Zika virus disease epidemic and on Public health risks related to communicable diseases at the Rio de Janeiro Olympic and Paralympic Games, Brazil, 2016.

Scientific advice

Official websites

European Union

World Health Organization

US CDC - Centers for Disease Control and Prevention